Clinical Report: FURL vs Mini-PCNL in 2 to 3 cm Stones
Overview
Flexible ureteroscopy with lithotripsy using suction technology achieved stone-free rates comparable to mini-PCNL in a noninferiority trial for 2 to 3 cm renal stones.
Background
The management of renal stones, particularly those measuring 2 to 3 cm, is crucial due to the potential for complications such as infection and bleeding, and the need for effective treatment options.
Data Highlights
Procedure
Immediate SFR
3-Month SFR
FURL
84%
90%
Mini-PCNL
85%
92%
Key Findings
FURL achieved immediate stone-free rates of 84% and 90% at 3 months.
Mini-PCNL had immediate stone-free rates of 85% and 92% at 3 months.
FURL was associated with lower intrarenal pressure and shorter hospital stays.
Patients treated with FURL reported improved quality of life post-procedure.
Both procedures showed favorable safety profiles, particularly in pediatric and complex cases.
Further large-scale trials are warranted to solidify the role of FURL in clinical practice.
Clinical Implications
Clinicians should consider suction-assisted FURL as a viable alternative to mini-PCNL for patients with 2 to 3 cm renal stones, particularly given its benefits in reducing intrarenal pressure and postoperative pain. Individualized treatment plans should take into account stone characteristics, patient factors, and comprehensive assessment.
Conclusion
Suction-assisted FURL presents a promising option for managing moderate renal stone burdens, with outcomes comparable to mini-PCNL. Further large-scale trials are warranted to solidify its role in clinical practice.
These 10 states have paid family or medical leave programs and health, wellness, peer support, or monitoring resources available to physicians or other health professionals.
